Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. (2017)
Attributed to:
University of Oxford Confidence in Concept Scheme – Round 4
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40478-017-0495-8
PubMed Identifier: 29208041
Publication URI: http://europepmc.org/abstract/MED/29208041
Type: Journal Article/Review
Volume: 5
Parent Publication: Acta neuropathologica communications
Issue: 1
ISSN: 2051-5960